Aurobindo Receives FDA Approval for Carbidopa Tablets, 25 mg
East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Carbidopa Tablets, 25 mg. Aurobindo’s Carbidopa Tablets, 25 mg are an AB-rated generic equivalent to the reference listed drug, Bausch Health Americas, Inc.’s Lodosyn® Tablets, 25mg. Carbidopa Tablets are indicated for use […]
Aurobindo Receives FDA Approval for Carbidopa Tablets, 25 mg Read More »